Indeed, decreased expression of PPARα was found in the brains of AD patients and was associated with weaker anti-oxidative and anti-inflammatory processes, as well as mitochondrial dysfunction and dysregulated APP processing [128]. This evidence concerns the gene APP and Alzheimer disease.